Henlius’ Trastuzumab Approved In China

Becomes First China-Developed mAb Biosimilar Approved In Both China And EU

 
• By David Wallace
  
Chinese - EU flags
Henlius’ trastuzumab biosimilar has been approved in both China and the EU • Source: Shutterstock

More from Biosimilars

More from Products